Covid-19: Baricitinib plus remdesivir shows promising
Washington – The combination of baricitinib, an anti-inflammatory drug, and remdesivir, an antiviral, reduced time to recovery for people hospitalized with COVID-19, according to clinical trial results published in the New England Journal of Medicine. The study was supported by the … Continue reading Covid-19: Baricitinib plus remdesivir shows promising
U.S. adds four more Chinese firms to Pentagon blacklist
WASHINGTON – Washington is poised to designate four more Chinese companies as backed by the Chinese military, sources said, curbing their access to U.S. investors as the Trump administration seeks to cement its hawkish China legacy in its waning days. … Continue reading U.S. adds four more Chinese firms to Pentagon blacklist
China congratulates Biden on winning the presidency
BEIJING – China on Friday congratulated U.S. President-elect Joe Biden, who won the Nov. 3 election that President Donald Trump has not conceded, nearly a week after the former vice president clinched enough states for the win. “We respect the … Continue reading China congratulates Biden on winning the presidency
COVID Vaccine: Moderna is conducting a clinical trial
Washington – Moderna has finished accumulating data for a first analysis of its COVID-19 vaccine and expects to have an announcement on the vaccine’s efficacy by the end of the month, the company said in a statement Wednesday. Pfizer announced Monday that … Continue reading COVID Vaccine: Moderna is conducting a clinical trial
COVID-19: NIH begins large clinical trial
Washington – The National Institutes of Health has launched an adaptive Phase 3 clinical trial to evaluate the safety and efficacy of three immune modulator drugs in hospitalized adults with COVID-19. Some COVID-19 patients experience an immune response in which … Continue reading COVID-19: NIH begins large clinical trial